Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
PDC-CRO (pdc-cro.com) is a full-service Contract Research Organization (CRO) that focuses exclusively on the Middle East and Africa (MEA) region. Its core business is providing end-to-end clinical research outsourcing services for pharmaceutical companies, biotech firms, and research institutions spanning from Phase I to Phase IV drug development. Leveraging deep regional regulatory experience and an extensive local resource network, it helps clients advance new drug clinical development and market access in the MEA region.
The official website clearly presents a full-process service matrix: for clinical stages, it offers execution services including clinical operations, trial site management, patient recruitment, and clinical monitoring; for supporting functions, it covers regulatory consulting, data management, biostatistical analysis, medical writing, and pharmacovigilance; it also provides extended services such as real-world evidence research, health economics and outcomes research, and regional clinical research capacity building training. Its services cover a range of high-demand therapeutic areas including infectious diseases, rare diseases, oncology, metabolic diseases, and cardiovascular diseases, with operations spanning more than 15 countries across the MEA region.
Most members of the core team come from multinational pharmaceutical giants like Novartis and Roche and leading global CROs, with an average of over 15 years of industry experience. They have built deep expertise in MEA regional regulatory requirements and local clinical resources, and effectively solve pain points related to compliance and implementation for cross-regional trials.
Pros: The PDC-CRO team has solid professional backgrounds and abundant local resources, with a flexible service model that supports both full-process outsourcing and customized module services. It can adapt to the needs of R&D projects of all sizes, and it is one of the few professional CROs that focuses in depth exclusively on the MEA region.
Cons: The official website does not disclose any pricing information, and users have to contact the team separately to inquire. Additionally, its business only covers the MEA region, with no service capability for other regions, and it does not offer Chinese language support for Chinese users.
Currently, the website can be accessed directly and normally from China, with smooth page loading. This service is an ideal choice for global pharmaceutical companies and biotech firms that plan to enter the MEA market and need to conduct clinical trials in the region.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on pdc-cro.com official site.
pdc-cro.com is an Croatia Health provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of China direct-connect friendly. Click "Visit Official Site" to reach pdc-cro.com directly.